Doctor profile · Federal record
Dr. Loganathan Elangovan, MD
Nephrology Physician (CMS: Nephrology) · Waukesha, WI
- NPI 1477572881
- Accepts Medicare
- 34 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1260 Sentry Dr Ste 140
Waukesha, WI 531865990
(262) 524-1024
fax (262) 524-8767
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- December 22, 2020
- Year of graduation
- 1992 — 34 yrs since
- Specialty taxonomy
- 207RN0300X — NUCC code
- State license (1)
- Wisconsin #40898-020
- Medicaid
- WI #32616600
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1477572881. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
33,603
Distinct HCPCS
10
Medicare allowed
$829,731
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J3111 |
Injection, romosozumab-aqqg, 1 mg | 24,360 | 20 | $10 | |
J0897 |
Injection, denosumab, 1 mg | 5,820 | 59 | $23 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 1,128 | 735 | $85 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 773 | 290 | $74 | |
90960 |
Dialysis services, 4 or more physician visits per month (20 years or older) | 458 | 64 | $333 | |
99223 |
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 254 | 224 | $163 | |
96372 |
Injection of drug or substance under skin or into muscle | 213 | 74 | $13 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 158 | 140 | $120 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 151 | 96 | $112 | |
90966 |
Home dialysis services per month (20 years or older) | 109 | 23 | $276 |
In context: peer comparison
Among 1 peers in Waukesha Nephrology Physician, average services per provider: 2,400. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$794
Transactions
16
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Amgen INC. | 6 | $316.35 | |
| Novartis Pharmaceuticals Corporation | 4 | $160.92 | |
| Mallinckrodt Hospital Products INC. | 1 | $121.83 | |
| Sanofi-Aventis U.S. LLC | 1 | $117.49 | |
| Ardelyx, INC. | 1 | $26.56 | |
| Akebia Therapeutics INC | 1 | $24.61 | |
| Novo Nordisk INC | 1 | $18.77 | |
| Travere Therapeutics, INC. | 1 | $7.96 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,031
Patients
1,161
Total drug cost
$225,313
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Furosemide | Generic | 478 | 155 | $3,360 |
| Valsartan | Generic | 413 | 101 | $12,132 |
| Carvedilol | Generic | 388 | 91 | $4,365 |
| Doxazosin Mesylate | Generic | 360 | 96 | $8,855 |
| Spironolactone | Generic | 336 | 100 | $5,083 |
| Losartan Potassium | Generic | 294 | 91 | $3,590 |
| Bumetanide | Generic | 288 | 95 | $12,484 |
| Amlodipine Besylate | Generic | 267 | 81 | $1,819 |
| Allopurinol | Generic | 258 | 74 | $3,919 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 195 | 33 | $140,117 |
Hospital affiliations
Frequently asked questions
What is Dr. Loganathan Elangovan's medical specialty?
Dr. Loganathan Elangovan practices Nephrology Physician in Waukesha, WI.
Where does Dr. Loganathan Elangovan practice?
Dr. Loganathan Elangovan practices at 1260 Sentry Dr Ste 140, Waukesha, WI 531865990. Office phone: 2625241024.
What is Dr. Loganathan Elangovan's NPI?
Dr. Loganathan Elangovan's National Provider Identifier (NPI) is 1477572881, issued by NPPES.
Does Dr. Loganathan Elangovan accept Medicare assignment?
Yes. Dr. Loganathan Elangovan accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Loganathan Elangovan commonly perform?
Top Medicare-reported procedures in 2023: Injection, romosozumab-aqqg, 1 mg (HCPCS J3111); Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.